Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM PAR
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
1,425,970
-
Shares change
-
-168,692
-
Total reported value, excl. options
-
$7,343,000
-
Value change
-
-$971,101
-
Number of buys
-
7
-
Number of sells
-
-7
-
Price
-
$5.15
Significant Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q4 2019
24 filings reported holding ICCC - IMMUCELL CORP /DE/ - COM PAR as of Q4 2019.
IMMUCELL CORP /DE/ - COM PAR (ICCC) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,425,970 shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (683,334 shares), RENAISSANCE TECHNOLOGIES LLC (110,106 shares), Antara Capital LP (105,000 shares), PERRITT CAPITAL MANAGEMENT INC (96,900 shares), INGALLS & SNYDER LLC (96,245 shares), VANGUARD GROUP INC (94,581 shares), MORGAN STANLEY (58,406 shares), SHUFRO ROSE & CO LLC (50,670 shares), Strategic Financial Services, Inc, (28,028 shares), and HM PAYSON & CO (25,500 shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.